Phillips-Medisize said today it completed the roll-out of its third-gen Connected Health Platform, a cloud-based data system for pharmaceutical and drug delivery device developers.
The newly launched system includes information sharing and analytics capabilities as well as cybersecurity precautions and streamlined regulatory documentation, the Hudson, Wisc.-based company said.
The third-gen Connected Health Platform includes an analytics platform intended for connected drug delivery devices, biosensors and regulated Mobile Medical Applications, Phillips-Medisize said.
The system can also integrate healthcare data from multiple sources with its master patient index, the company said. That data can be made actionable for payers, providers and pharma, and allows for data normalization across geographies for appropriate global comparison.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
“Our CHP further demonstrates our commitment to creating innovative solutions for our customers. This allows clients to quickly change or fine-tune reports without the need for costly, time-consuming software development. We are providing the tools needed to extract powerful health and market insights. By offering our platform as a service, we’re responsible for data security, management and storage. That gives our customers the freedom to focus on what they do best – creating connected health solutions that provide better patient experiences and facilitate improved patient outcomes,” prez & CEO Matt Jennings said in a press release.
Earlier this month, Phillips-Medisize said that it teamed up with healthcare software tech company InterSystems to develop a data-sharing and analytics platform designed for connected drug-delivery devices and mobile medical apps.
Date: November 6, 2018
Source: Drug Delivery